Literature DB >> 8027407

Use of Sentinel blood culture system for analysis of specimens from potentially infected prosthetic joints.

S Baker1, A P Fraise.   

Abstract

The Sentinel blood culture system was used for the analysis of 657 specimens from infected prosthetic joints and blood cultures (83 from prosthetic joints and 574 from standard blood cultures). The positivity rate was similar for specimens from prosthetic joints and blood cultures (18% compared with 14%). However, there was an unacceptable rate of false positive results with specimens from prosthetic joints (58% compared with 8%). This high false positivity rate was due to (i) prolonged incubation and (ii) the lack of blood in these specimens. It is therefore recommended that the Sentinel system should only be used for the initial seven days of incubation of specimens taken from prosthetic joints. Further incubation should take place in a standard incubator and a terminal subculture performed after 21 days.

Entities:  

Mesh:

Year:  1994        PMID: 8027407      PMCID: PMC502034          DOI: 10.1136/jcp.47.5.475

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  3 in total

1.  Diagnosing infection in hip replacements. The use of fine-needle aspiration and radiometric culture.

Authors:  P Roberts; A J Walters; D J McMinn
Journal:  J Bone Joint Surg Br       Date:  1992-03

2.  The isolation of bacteria of low pathogenicity from faulty orthopaedic implants.

Authors:  W Whyte; R Hodgson; J Tinkler; J Graham
Journal:  J Hosp Infect       Date:  1981-09       Impact factor: 3.926

3.  Clinical and microbial features of prosthetic joint infection.

Authors:  R D Inman; K V Gallegos; B D Brause; P B Redecha; C L Christian
Journal:  Am J Med       Date:  1984-07       Impact factor: 4.965

  3 in total
  1 in total

Review 1.  Emperor's new clothes: Is particle disease really infected particle disease?

Authors:  Marcin K Wasko; Stuart B Goodman
Journal:  J Orthop Res       Date:  2016-05-30       Impact factor: 3.494

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.